Lucas A Mavromatis

7PUBLICATIONS
15CO-AUTHORS
Molecular targetsGene expression (incl. microarray and other genome-wide approaches)Nutrigenomics and personalised nutritionCardiology (incl. cardiovascular diseases)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 01, 2025
Glucagon-like peptide-1 receptor agonists and incidence of obesity-related cancer in adults with diabetes: A target-trial emulation study.

Lucas A Mavromatis, Aditya Surapaneni, Sneha Mehta

|Nov 11, 2024
A multi-omics Mendelian randomization study identifies new therapeutic targets for alcohol use disorder and problem drinking.

Daniel B Rosoff, Josephin Wagner, Andrew S Bell

|Nov 04, 2024
PREVENT Risk Score and Use of Cardioprotective Agents in Type 2 Diabetes: An Analysis of NHANES 2013 to 2020.

Lucas A Mavromatis, Dan Wang, Elizabeth Selvin

|Jan 23, 2024
Evaluating the Cardiovascular Impact of Genetically Proxied PCSK9 and HMGCR Inhibition in East Asian and European Populations: A Drug-Target Mendelian Randomization Study.

Daniel B Rosoff, Andrew S Bell, Lucas A Mavromatis

|Aug 07, 2023
Multivariate genome-wide analysis of aging-related traits identifies novel loci and new drug targets for healthy aging.

Daniel B Rosoff, Lucas A Mavromatis, Andrew S Bell

|Apr 19, 2023
Multi-omic underpinnings of epigenetic aging and human longevity.

Lucas A Mavromatis, Daniel B Rosoff, Andrew S Bell

Pageof 2

Frequent Collaborators

5 joint publications

Jeesun Jung

5 joint publications

Falk W Lohoff

3 joint publications

Josephin Wagner

2 joint publications

Andrew S Bell